Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice

International Journal of Clinical Practice

Volumn 59, Issue 6, 2005, Pages 632-638

  Luders S ^a   Hammersen, F ^a   Kulschewski, A ^a   Venneklaas, U ^a   Zuchner C ^a   Gansz, A ^b   Schnieders, M ^b   Pfarr, E ^c   Sturm, C D ^d   Paar, W D ^d   Schrader, J ^a  

^a ST JOSEFS HOSPITAL   (Germany)

^b INFO GmbH Institute for Hypertension and Cardiovascular Research   (Germany)

^c AMS Advanced Medical Services GmbH   (Germany)

^d SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Hypertension; Impaired glucose tolerance; Oral glucose tolerance test; Pre diabetes; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; AGING; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; ROC CURVE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE; ANALYSIS OF VARIANCE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 23844460605     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00518.x     Document Type: Article

References (26)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Shen DC, Shieh SM, Fuh MM et al. Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580-3.
3. Bakris GI, Sowers JR. When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk? Hypertension 2004; 43: 941-2.
4. Verdecchia P, Reboldi G, Angeli F et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43: 963-9. 10.1161/01.HYP.0000125726.92964.ab
5. Rathmann W, Haasters B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-9.
6. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-31. 10.1007/BF00274216
7. Meigs JB, Nathan DM, Wilson PWF et al. Metabolic risk factors worsen continuously across the spectrum of non-diabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med 1998; 128: 524-33.
8. Christ M, Klima T, Maisch B. Arterial hypertension and metabolic syndrome. Herz 2003; 28: 674-85.
9. Saad F, Rewers M, Selby J et al. Insulin resistance and hypertension. Hypertension 2004; 42: 1-8.
10. Orchard TJ. Kelly West Lecture 1993: From diagnoses and classification to complications and therapy: DCCT Part II. Diabetes Care 1994; 17: 326-38.
11. Stolk RP, Orchard TJ, Grobbee DE. Why use the oral glucose tolerance test? (Commentary). Diabetes Care 1995; 18: 1045-9.
12. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2003; 26: S21-4.
13. Kerner W, Fuchs C, Redaelli M et al. Klassifikation and Diagnostik des Diabetes mellitus. In: Scherbaum WA, Lauterbach KW, Joost HG, eds. Evidenzbasierte Diabetes-Leitlinien DDG, 1st edn. Deutsche: Diabetes-Gesellschaft, 2001.
14. Schianca GPC, Rossi A, Sainaghi PP et al. The significance of impaired fasting glucose versus impaired glucose tolerance - importance of insulin secretion and resistance. Diabetes Care 2003; 26: 1333-7.
15. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 DM: Do we need the oral glucose tolerance test? Ann Intern Med 2002; 136: 575-81.
16. Herman WH, Smith PJ, Thompson TJ et al. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995; 18: 382-7.
17. Perry RC, Shankar RR, Fineberg N et al. HbA1c measurement improves the detection of type 2 diabetes in high risk individuals with non-diagnostic levels of fasting plasma glucose. Diabetes Care 2001; 24: 465-71.
18. Colagiuri S, Zafirul H, Paul Z et al. Screening for type 2 diabetes and impaired glucose metabolism. The Australian Experience. Diabetes Care 2004; 27: 367-71.
19. Gerstein H. Fasting versus postload glucose levels. Why the controversy? Diabetes Care 2001; 24: 1855-6.
20. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol (Adults Treatment Panel III). JAMA 2001; 285: 2486-97.
21. Gundy SM, Brewer HB, Cleeman JI et al. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-8.
22. Saydah SH, Byrd-Holt D, Harris MI. Projected impact of implementing the results of the diabetes prevention program in the US population. Diabetes Care 2002; 25: 1940-5.
23. Herdzik E, Safranow K, Ciechanowski K. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Acta Diabetol 2002; 39: 15-22. 10.1007/ s005920200007
24. Wiener K, Roberts NB. The relative merits of haemoglobin A1c and fasting plasma glucose tolerance as first line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med 1998; 15: 558-63. 10.1002/ (SICI)1096-9136(199807)15:7<558::AID-DIA669>3.3.CO;2-H
25. Liao Y, Kwon S, Shaugnessy P et al. Critical evaluation of Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidaemia. Diabetes Care 2004; 27: 978-83.
26. Stevens J, Couper D, Pankow J et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 2001; 9: 696-705.